{"id":5290,"date":"2022-09-29T16:20:23","date_gmt":"2022-09-29T19:20:23","guid":{"rendered":"https:\/\/hml.artica.capital\/clairfield-pilulas\/ma-no-setor-de-farmacos\/"},"modified":"2026-09-28T20:34:13","modified_gmt":"2026-09-28T23:34:13","slug":"ma-no-setor-de-farmacos","status":"publish","type":"pilulas","link":"https:\/\/hml.artica.capital\/en\/clairfield-pilulas\/ma-no-setor-de-farmacos\/","title":{"rendered":"M&#038;A no setor de f\u00e1rmacos"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">A produ\u00e7\u00e3o de f\u00e1rmacos \u00e9 marcada pela necessidade de investimentos massivos em inova\u00e7\u00e3o e fabrica\u00e7\u00e3o de novos produtos, al\u00e9m de incertezas associadas \u00e0 efetividade dos medicamentos em desenvolvimento.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Buscando superar as dificuldades inerentes do setor, movimenta\u00e7\u00f5es importantes aconteceram no Brasil nos \u00faltimos anos, seguindo uma tend\u00eancia de consolida\u00e7\u00e3o das grandes empresas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A p\u00edlula de hoje destaca quais as principais motiva\u00e7\u00f5es estrat\u00e9gicas para realiza\u00e7\u00e3o de M&amp;As no setor de f\u00e1rmacos, trazendo exemplos de transa\u00e7\u00f5es envolvendo companhias brasileiras.<\/p>\n\n\n\n<!-- pilula-html v1 -->\n<style>\n.pil{--navy:#2d3a51;--blue:#4f6388;--light:#8599b9;--pale:#e8ebf1;--card:#d3d9e3;--red:#c0272d;--txt:#333;font-family:\"Merriweather Sans\",sans-serif;color:var(--txt);margin-top:40px}\n.pil *{box-sizing:border-box}\n.pil img{max-width:100%;height:auto;display:block}\n.pil-sec{margin:0 0 56px}\n.pil-sec h2{background:var(--navy);color:#fff;font-size:19px;line-height:1.35;font-weight:700;padding:16px 20px;border-radius:0 0 28px 0;margin:0 0 20px;text-wrap:balance}\n.pil-sub{font-size:14px;font-weight:700;color:var(--navy);border-bottom:2px solid var(--navy);padding-bottom:6px;margin:0 0 16px;display:flex;justify-content:space-between;gap:12px;align-items:flex-end}\n.pil-tag{color:var(--red);border-top:2px solid var(--red);border-bottom:2px solid var(--red);font-size:12px;padding:2px 8px;white-space:nowrap}\n.pil-unit{font-size:12px;font-style:italic;color:#999;font-weight:700}\n.pil-src{font-size:11px;color:#777;margin-top:14px;line-height:1.5}\n.pil-p{font-size:14px;line-height:1.6;margin:0 0 12px}\n.pil-note{display:flex;gap:12px;align-items:center;background:var(--pale);border:1.5px dashed var(--navy);border-radius:10px;padding:12px 16px;font-size:14px;line-height:1.55;margin-top:18px}\n.pil-note::before{content:\"\";flex:none;width:26px;height:26px;border-radius:50%;background:var(--navy) url(\"data:image\/svg+xml,%3Csvg xmlns='http:\/\/www.w3.org\/2000\/svg' viewBox='0 0 24 24' fill='none' stroke='white' stroke-width='1.8' stroke-linecap='round'%3E%3Cpath d='M9 18h6M10 21h4M12 3a6 6 0 0 0-3.5 10.9c.6.5 1 1.2 1 2.1h5c0-.9.4-1.6 1-2.1A6 6 0 0 0 12 3z'\/%3E%3C\/svg%3E\") center\/16px no-repeat}\n.pil-note.solid{border-style:solid;background:#fff;box-shadow:0 2px 6px rgba(0,0,0,.12)}\n.pil-note.solid::before{display:none}\n.pil-grid2{display:grid;grid-template-columns:1fr 1fr;gap:24px}\n.pil-grid2.wide-left{grid-template-columns:1.75fr 1fr}\n.pil-grid2.wide-right{grid-template-columns:1fr 1.75fr}\n.pil-grid3{display:grid;grid-template-columns:repeat(3,1fr);gap:20px}\n.pil-grid4{display:grid;grid-template-columns:repeat(4,1fr);gap:16px}\n.pil-grid5{display:grid;grid-template-columns:repeat(5,1fr);gap:12px}\n.pil-grid2>*,.pil-grid3>*,.pil-grid4>*,.pil-grid5>*{min-width:0}\n.pil-legend{font-size:12px;display:flex;gap:14px;justify-content:flex-end;flex-wrap:wrap;margin-bottom:6px}\n.pil-legend span{display:inline-flex;align-items:center;gap:6px}\n.pil-legend i{width:14px;height:10px;display:inline-block}\n\/* grafico de colunas: .pil-bars > div[style=height:%] > span (valor); .pil-years > span *\/\n.pil-bars{display:flex;align-items:flex-end;gap:2.2%;height:240px;border-bottom:1.5px solid #333;padding:22px 1% 0}\n.pil-bars>div{flex:1;background:var(--light);position:relative;min-height:1px}\n.pil-bars>div.e{background:var(--blue)}\n.pil-bars>div.cur{background:var(--navy)}\n.pil-bars>div>span{position:absolute;top:-19px;left:50%;transform:translateX(-50%);font-size:12px;white-space:nowrap}\n.pil-years{display:flex;gap:2.2%;padding:4px 1% 0;font-size:11px;text-align:center}\n.pil-years span{flex:1}\n.pil-cagr{text-align:center;font-size:12px;font-weight:700}\n.pil-cagr span{display:inline-block;border:1.5px solid #222;border-radius:50%;padding:2px 8px;margin-top:4px}\n\/* barras horizontais: .pil-hbars > .r > (b nome) (.bar > i[style=width:%]) (em valor) *\/\n.pil-hbars{display:grid;gap:8px;font-size:13px}\n.pil-hbars .r{display:grid;grid-template-columns:minmax(90px,30%) 1fr auto;gap:10px;align-items:center}\n.pil-hbars .bar{background:var(--pale);height:18px}\n.pil-hbars .bar i{display:block;height:100%;background:var(--blue)}\n.pil-hbars em{font-style:normal;font-weight:700;color:var(--navy);min-width:48px;text-align:right}\n\/* cartoes de numeros *\/\n.pil-box{border:2px solid var(--navy);border-radius:0 0 10px 10px;background:#fff}\n.pil-box>h3{margin:0;background:var(--navy);color:#fff;font-size:14px;text-align:center;padding:8px}\n.pil-stat{text-align:center;padding:16px 14px;font-size:13px;line-height:1.45}\n.pil-stat strong{display:block;font-size:40px;color:var(--blue);font-weight:800;line-height:1.1}\n.pil-stat strong small{font-size:22px}\n.pil-stat em{font-style:normal;color:var(--blue);font-weight:700}\n.pil-card{background:#fff;border-radius:12px;box-shadow:0 1px 5px rgba(0,0,0,.14);padding:14px 16px;font-size:13px;line-height:1.5}\n.pil-card h3{font-size:15px;color:var(--navy);margin:0 0 8px}\n.pil-card.tint{background:var(--card);box-shadow:none}\n\/* listas e fatos *\/\n.pil-list{margin:0;padding-left:18px;font-size:14px;line-height:1.6}\n.pil-list li{margin-bottom:6px}\n.pil-fact{font-size:14px;line-height:1.5;padding-left:14px;border-left:3px solid var(--light)}\n.pil-fact.dark{border-color:var(--navy)}\n.pil-fact b{color:var(--navy)}\n.pil-fact big{font-size:20px;font-weight:800;color:var(--navy)}\n.pil-hl{color:var(--blue);font-weight:700}\n\/* tabela *\/\n.pil-tw{overflow-x:auto}\n.pil-table{width:100%;border-collapse:collapse;font-size:13px}\n.pil-table th{background:var(--navy);color:#fff;text-align:left;padding:8px 10px;font-weight:700}\n.pil-table td{padding:7px 10px;border-bottom:1px solid #d8dce4;vertical-align:top}\n.pil-table tr:nth-child(even) td{background:#f5f6f9}\n.pil-table .n{text-align:right;font-variant-numeric:tabular-nums;white-space:nowrap}\n\/* linha do tempo *\/\n.pil-time{display:grid;gap:14px;border-left:2px dashed var(--light);padding-left:18px;margin-left:6px}\n.pil-time>div{position:relative;font-size:14px;line-height:1.5}\n.pil-time>div::before{content:\"\";position:absolute;left:-25px;top:5px;width:12px;height:12px;border-radius:50%;background:var(--navy)}\n.pil-time b.y{display:block;color:var(--light);font-size:16px;font-weight:800}\n\/* figuras (recortes do slide) *\/\n.pil-fig{margin:0}\n.pil-fig figcaption{text-align:center;font-weight:800;color:var(--light);font-size:16px;margin-top:4px}\n.pil-brand{background:var(--card);border-radius:14px;overflow:hidden}\n.pil-brand p{margin:0;text-align:center;font-size:20px;font-weight:800;font-style:italic;color:var(--navy);padding:10px 0 12px}\n@media (max-width:700px){\n  .pil-grid2,.pil-grid2.wide-left,.pil-grid2.wide-right{grid-template-columns:1fr}\n  .pil-grid3,.pil-grid4,.pil-grid5{grid-template-columns:1fr 1fr}\n  .pil-sec h2{font-size:17px}\n  .pil-bars{height:180px}\n  .pil-bars>div>span{font-size:10px}\n  .pil-years{font-size:9px}\n}\n@media (max-width:480px){\n  .pil-bars{gap:1.2%}\n  .pil-years{gap:1.2%;font-size:8px}\n  .pil-bars>div>span{font-size:8px;letter-spacing:-.3px}\n  .pil-bars:has(>div:nth-child(13))>div>span{writing-mode:vertical-rl;transform:translateX(-50%) rotate(180deg);top:auto;bottom:100%;padding-bottom:2px}\n  .pil-years:has(>span:nth-child(13)) span{writing-mode:vertical-rl;transform:rotate(180deg);margin:0 auto}\n}\n<\/style>\n<div class=\"pil\">\n\n<section class=\"pil-sec\">\n  <h2>M&amp;As s\u00e3o alavancas-chave para o setor de desenvolvimento de f\u00e1rmacos, com 3 principais motiva\u00e7\u00f5es em destaque:<\/h2>\n  <div class=\"pil-sub\">Alavanca Estrat\u00e9gica<\/div>\n  <div class=\"pil-grid3\">\n    <div class=\"pil-card\" style=\"text-align:center\"><h3>Inova\u00e7\u00e3o<\/h3>A grande quantidade de etapas envolvida no desenvolvimento de um f\u00e1rmaco motiva a <span class=\"pil-hl\">aquisi\u00e7\u00e3o de empresas menores e com mais <i>expertise<\/i> em processos espec\u00edficos.<\/span><\/div>\n    <div class=\"pil-card\" style=\"text-align:center\"><h3>Economias de Escala<\/h3>Da pesquisa \u00e0 comercializa\u00e7\u00e3o do f\u00e1rmaco, existem grandes oportunidades de <span class=\"pil-hl\">parcerias estrat\u00e9gicas para reduzir custos e aumentar efici\u00eancia operacional.<\/span><\/div>\n    <div class=\"pil-card\" style=\"text-align:center\"><h3>Realinhamento de Portf\u00f3lio<\/h3>O longo processo de desenvolvimento de um f\u00e1rmaco exige um <span class=\"pil-hl\">portf\u00f3lio bem estruturado, com gera\u00e7\u00e3o de caixa suficiente at\u00e9 que novas patentes sejam obtidas.<\/span><\/div>\n  <\/div>\n  <div class=\"pil-sub\" style=\"margin-top:28px\">Opera\u00e7\u00e3o<\/div>\n  <div class=\"pil-grid3\">\n    <div class=\"pil-card\" style=\"text-align:center;background:#f2f2f2\"><img decoding=\"async\" src=\"https:\/\/hml.artica.capital\/wp-content\/uploads\/2026\/09\/5290-ache.png\" alt=\"Logos da Ach\u00e9 e do Laborat\u00f3rio Tiaraju\" loading=\"lazy\" style=\"margin:0 auto 8px\">Ach\u00e9 adquirindo laborat\u00f3rio ga\u00facho Tiaraju, experiente no segmento de nutri cosm\u00e9ticos.<\/div>\n    <div class=\"pil-card\" style=\"text-align:center;background:#f2f2f2\"><img decoding=\"async\" src=\"https:\/\/hml.artica.capital\/wp-content\/uploads\/2026\/09\/5290-hypera.png\" alt=\"Logos da Hypera Pharma e da Sanofi\" loading=\"lazy\" style=\"margin:0 auto 8px\">Hypera adquirindo ativos da Sanofi para integrar a produ\u00e7\u00e3o de medicamentos e diluir despesas.<\/div>\n    <div class=\"pil-card\" style=\"text-align:center;background:#f2f2f2\"><img decoding=\"async\" src=\"https:\/\/hml.artica.capital\/wp-content\/uploads\/2026\/09\/5290-eurofarma.png\" alt=\"Logos da Eurofarma e da Takeda\" loading=\"lazy\" style=\"margin:0 auto 8px\">Eurofarma adquirindo ativos da Takeda em pa\u00edses da Am\u00e9rica Latina, expandindo sua opera\u00e7\u00e3o internacionalmente e ampliando o portf\u00f3lio protegido por patentes<\/div>\n  <\/div>\n  <div class=\"pil-src\">Fonte: McKinsey &#8211; A new prescription for M&amp;A in pharma; <i>Clippings;<\/i> An\u00e1lise \u00c1rtica<\/div>\n<\/section>\n\n<\/div>\n\n","protected":false},"excerpt":{"rendered":"<p>A produ\u00e7\u00e3o de f\u00e1rmacos \u00e9 marcada pela necessidade de investimentos massivos em inova\u00e7\u00e3o e fabrica\u00e7\u00e3o de novos produtos, al\u00e9m de incertezas associadas \u00e0 efetividade dos medicamentos em desenvolvimento. Buscando superar as dificuldades inerentes do setor, movimenta\u00e7\u00f5es importantes aconteceram no Brasil nos \u00faltimos anos, seguindo uma tend\u00eancia de consolida\u00e7\u00e3o das grandes empresas. A p\u00edlula de hoje [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5288,"template":"","meta":[],"class_list":["post-5290","pilulas","type-pilulas","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/hml.artica.capital\/en\/wp-json\/wp\/v2\/pilulas\/5290","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hml.artica.capital\/en\/wp-json\/wp\/v2\/pilulas"}],"about":[{"href":"https:\/\/hml.artica.capital\/en\/wp-json\/wp\/v2\/types\/pilulas"}],"author":[{"embeddable":true,"href":"https:\/\/hml.artica.capital\/en\/wp-json\/wp\/v2\/users\/1"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hml.artica.capital\/en\/wp-json\/wp\/v2\/media\/5288"}],"wp:attachment":[{"href":"https:\/\/hml.artica.capital\/en\/wp-json\/wp\/v2\/media?parent=5290"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}